Annual report pursuant to Section 13 and 15(d)

Non-controlling Interest (Details Textual)

v3.6.0.2
Non-controlling Interest (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Aug. 31, 2015
Aug. 29, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Noncontrolling Interest [Line Items]          
Equity Method Investment, Ownership Percentage     88.50%    
Net Income (Loss) Attributable to Noncontrolling Interest, Total     $ (548,000) $ (1,048,000) $ 0
Noncontrolling Interest, Ownership Percentage by Parent     11.50%    
Stockholders Equity Attributable to Noncontrolling Interest     $ (1,596,000) $ (1,048,000)  
Consolidation, Eliminations [Member]          
Noncontrolling Interest [Line Items]          
Net Income (Loss) Attributable to Noncontrolling Interest, Total     548,000    
Dr. Pimentels [Member] | Consolidation, Eliminations [Member]          
Noncontrolling Interest [Line Items]          
Stockholders Equity Attributable to Noncontrolling Interest     $ 505,000    
Biomics and Mark Pimentel [Member]          
Noncontrolling Interest [Line Items]          
Noncontrolling Interest, Ownership Percentage by Parent   8.50% 11.50%    
Stock Purchase Agreement [Member]          
Noncontrolling Interest [Line Items]          
Conversion of Stock, Shares Converted   1,350,000      
Conversion of Stock, Shares Issued 1,350,000 1,350,000